SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
7636536
Source:
http://linkedlifedata.com/resource/pubmed/id/7636536
Search
Subject
(
60
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0007134
,
umls-concept:C0030705
,
umls-concept:C0042670
,
umls-concept:C0205179
,
umls-concept:C0280858
,
umls-concept:C1519043
pubmed:issue
8
pubmed:dateCreated
1995-9-11
pubmed:abstractText
The reduced cardiac toxicity of the dextro-(d-) stereoisomer of verapamil (dexverapamil; Knoll Pharmaceuticals, Whippany, NJ) warrants its study as a potential multidrug-resistance (MDR) reversal agent.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/P-Glycoprotein
,
http://linkedlifedata.com/resource/pubmed/chemical/Verapamil
,
http://linkedlifedata.com/resource/pubmed/chemical/Vinblastine
,
http://linkedlifedata.com/resource/pubmed/chemical/norverapamil
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0732-183X
pubmed:author
pubmed-author:Cordon-CardoCC
,
pubmed-author:FischerPP
,
pubmed-author:GoM LML
,
pubmed-author:LianesPP
,
pubmed-author:MotzerR JRJ
,
pubmed-author:NgoR LRL
,
pubmed-author:O'BrienJ PJP
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1958-65
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:7636536-Adult
,
pubmed-meshheading:7636536-Aged
,
pubmed-meshheading:7636536-Bradycardia
,
pubmed-meshheading:7636536-Carcinoma, Renal Cell
,
pubmed-meshheading:7636536-Drug Resistance, Multiple
,
pubmed-meshheading:7636536-Drug Therapy, Combination
,
pubmed-meshheading:7636536-Female
,
pubmed-meshheading:7636536-Humans
,
pubmed-meshheading:7636536-Hypotension
,
pubmed-meshheading:7636536-Immunohistochemistry
,
pubmed-meshheading:7636536-Kidney Neoplasms
,
pubmed-meshheading:7636536-Male
,
pubmed-meshheading:7636536-Middle Aged
,
pubmed-meshheading:7636536-P-Glycoprotein
,
pubmed-meshheading:7636536-Stereoisomerism
,
pubmed-meshheading:7636536-Tumor Cells, Cultured
,
pubmed-meshheading:7636536-Verapamil
,
pubmed-meshheading:7636536-Vinblastine
pubmed:year
1995
pubmed:articleTitle
Phase I/II trial of dexverapamil plus vinblastine for patients with advanced renal cell carcinoma.
pubmed:affiliation
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Controlled Clinical Trial
,
Research Support, Non-U.S. Gov't
,
Clinical Trial, Phase II
,
Clinical Trial, Phase I